Imbruvica União Europeia - letão - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinibs - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Lartruvo União Europeia - letão - EMA (European Medicines Agency)

lartruvo

eli lilly nederland b.v. - olaratumabs - sarkoma - antineoplastiski līdzekļi - lartruvo ir minēta kopā ar doxorubicin ārstēšana pieaugušiem pacientiem ar modernu mīksto audu sarkoma, kuri nav grozāmi dziednieciska terapija ar operācijas vai radioterapijas un kas nav iepriekš ārstēti ar doxorubicin (sk. 5. sadaļa.

Teysuno União Europeia - letão - EMA (European Medicines Agency)

teysuno

nordic group b.v. - ftorafūrs, gimeracil, oteracil - kuņģa-zarnu trakta traucējumi - antineoplastiski līdzekļi - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

APAPKIT 40 mg/ml suspensija iekšķīgai lietošanai Letônia - letão - Zāļu valsts aģentūra

apapkit 40 mg/ml suspensija iekšķīgai lietošanai

us pharmacia sp. z o.o., poland - paracetamols - suspensija iekšķīgai lietošanai - 40 mg/ml

Optilamid 10 mg/ml acu pilieni, suspensija Letônia - letão - Zāļu valsts aģentūra

optilamid 10 mg/ml acu pilieni, suspensija

zaklady farmaceutyczne polpharma s.a., poland - brinzolamīds - acu pilieni, suspensija - 10 mg/ml

Clarithromycin Ingen Pharma 250 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

clarithromycin ingen pharma 250 mg apvalkotās tabletes

ingen pharma, sia, latvia - klaritromicīns - apvalkotā tablete - 250 mg

Clarithromycin Ingen Pharma 500 mg apvalkotās tabletes Letônia - letão - Zāļu valsts aģentūra

clarithromycin ingen pharma 500 mg apvalkotās tabletes

ingen pharma, sia, latvia - klaritromicīns - apvalkotā tablete - 500 mg

Brizadopt 10 mg/ml acu pilieni, suspensija Letônia - letão - Zāļu valsts aģentūra

brizadopt 10 mg/ml acu pilieni, suspensija

bausch + lomb ireland limited, ireland - brinzolamīds - acu pilieni, suspensija - 10 mg/ml

Brinzolamide/Timolol Stada 10 mg/5 mg/ml acu pilieni, suspensija Letônia - letão - Zāļu valsts aģentūra

brinzolamide/timolol stada 10 mg/5 mg/ml acu pilieni, suspensija

stada arzneimittel ag, germany - brinzolamidum, timololum - acu pilieni, suspensija - 10 mg/5 mg/ml

Brinzolamide/Timolol Accord 10 mg/ml/5 mg/ml acu pilieni, suspensija Letônia - letão - Zāļu valsts aģentūra

brinzolamide/timolol accord 10 mg/ml/5 mg/ml acu pilieni, suspensija

accord healthcare b.v., netherlands - brinzolamidum, timololum - acu pilieni, suspensija - 10 mg/ml/5 mg/ml